# Beta Alanine Exercise Performance Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/beta-alanine-exercise-performance-meta-analysis-evidence-review
Category: evidence-review
Summary: Beta Alanine Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first 
Last reviewed: 2026-05-21
Reviewed by: Migaku Evidence Review
# Beta Alanine Exercise Performance Meta-analysis: What the Evidence Says

## Quick Answer

Beta Alanine Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials | systematic review | 1 | 2026-03-26 | 10.3389/fnut.2026.1818755 |
| Exercise-Induced Rhabdomyolysis With Supplements (Creatine, β-Alanine, Citrulline Malate, and β-Ecdysterone) | research article | 4 | 2026-03-08 | 10.7759/cureus.104852 |

## What The Sources Report

- Importantly, mechanistic evidence indicates that performance loss during repeated maximal efforts reflects an integrated disturbance in muscle function-encompassing substrate availability, metabolite/ionic perturbations, excitation-contraction coupling, and only later, more pronounced acid-base disruption-rather than a single dominant metabolite (-). [Liang Weibao (2026); evidence level 1]
- Consistent with this mechanism, contemporary meta-analytic evidence indicates the most reproducible ergogenic effects in high-intensity exercise tasks of approximately 1-4 min, where acid-base perturbation is more likely to be performance-limiting. [Liang Weibao (2026); evidence level 1]
- Rhabdomyolysis occurs as a result of the breakdown of the muscle cell membrane, leading to cell necrosis. [Muacevic Alexander (2026); evidence level 4]
- As a result of necrosis, potentially toxic intracellular substances, such as creatine kinase (CK), myoglobin, amino acids, and electrolytes, are released into the plasma. [Muacevic Alexander (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For beta alanine exercise performance meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Liang Weibao (2026). No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1818755. PMCID: PMC13061858. PMID: 41971372. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13061858/
- Muacevic Alexander (2026). Exercise-Induced Rhabdomyolysis With Supplements (Creatine, β-Alanine, Citrulline Malate, and β-Ecdysterone). DOI: 10.7759/cureus.104852. PMCID: PMC13055871. PMID: 41952948. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13055871/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.